A Prospective Study of Cardiovascular Risk of Patients Admitted for Acute Exacerbation of COPD
NCT07344285
Summary
This is a prospective study to assess the burden of existing or hidden cardiovascular (CV) and renal disease in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) in a Hong Kong public hospital setting. By implementing a chronic obstructive pulmonary disease (COPD) discharge care bundle with integrated CV/renal screening, the study aims to quantify undiscovered disease prevalence, evaluate risk factors for future exacerbations, and compare re-admission rates against historical controls, ultimately informing integrated cardiopulmonary management strategies.
Eligibility
Inclusion Criteria: * Age ≥40 years * Patients hospitalized due to COPD exacerbation. * Patients diagnosed with COPD, a confirmed COPD diagnosis with a specific FEV1/FVC ratio (\<0.70) * Able to provide informed consent Exclusion Criteria: * Pregnant subjects * Inability to give informed consent * Cancer patient who are on active chemotherapy or on palliative care
Conditions1
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT07344285